申请人:Hoffmann-La Roche Inc.
公开号:US05128470A1
公开(公告)日:1992-07-07
Compounds of the general formula ##STR1## wherein R.sup.1 is hydrogen, halogen or OR.sup.5 ; R.sup.2 is hydrogen, lower-alkyl, lower-alkoxy or halogen; R.sup.3 and R.sup.4 each independently are lower-alkyl or taken together are alkylene with 3-5 C atoms in a straight-chain; R.sup.5 is hydrogen, acyl, lower-alkoxycarbonyl, lower-alkyl, amino-lower-alkyl, mono-alkylamino-lower-alkyl, di-alkylamino-lower-alkyl or a N-containing 5-8-membered saturated or unsaturated monocyclic heterocyclic ring which is attached via a N atom to lower alkyl; and M signifies --CONH-- or --NHCO--, which can be used as medicaments, e.g., for the treatment of neoplasms and dermatological indications of an inflammatory and allergic nature.
通式为##STR1##的化合物,其中R.sup.1是氢、卤素或OR.sup.5;R.sup.2是氢、低烷基、低烷氧基或卤素;R.sup.3和R.sup.4各自独立地是低烷基,或者一起是直链上有3-5个碳原子的亚烷基;R.sup.5是氢、酰基、低烷氧羰基、低烷基、氨基-低烷基、单烷基氨基-低烷基、双烷基氨基-低烷基或通过N原子连接到低烷基的含N的5-8元饱和或不饱和单环杂环环;M表示--CONH--或--NHCO--,可用作药物,例如,用于治疗肿瘤和皮肤炎症和过敏性疾病。